Table 1: Patient characteristics and DFO use.

Inpatient Use of DFO DFO(n = 21) No DFO(n = 187)

Serum ferritin, ng/mL

8,873 (6,115-10,978)

(n = 20)

2,019 (747-5,226)

(n = 136)

Serum ferritin, n (%)

< 1,000 ng/mL

1,000-2,499 ng/mL

2,500-4,000 ng/mL

> 4,000 ng/mL

1 (5)

0

2 (10)

17 (85)

41 (30)

33 (24)

14 (10)

48 (36)

Blood transfusions during study, mL/kg

48 (19-54)

9 (0-27)

Patients on outpatient DFO

   Inpatient DFO dose, mg/kg

   Number of doses, median (range)

(n = 6)

82 (55-90)

2 (1-5)

(n = 7)

n/a

n/a

Patients on outpatient DFS

   Inpatient DFO dose, mg/kg

   Number of doses, median (range)

(n = 8)

17 (13-32)

1 (1-7)

(n = 26)

n/a

n/a

No outpatient chelation

   Inpatient DFO dose, mg/kg

   Number of doses, median (range)

(n = 6)

39 (15-55)

1 (1-2)

(n = 154)

n/a

n/a

DFO: Deferoxamine; DFS: Deferasirox; Data presented is median (1st-3rd quartile) unless otherwise noted.